By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. (DRTS)

NASDAQ Currency in USD
$3.83
+$0.08
+2.13%
Last Update: 11 Sept 2025, 20:00
$324.40M
Market Cap
-9.82
P/E Ratio (TTM)
Forward Dividend Yield
$2.11 - $4.39
52 Week Range

DRTS Stock Price Chart

Explore Alpha Tau Medical Ltd. interactive price chart. Choose custom timeframes to analyze DRTS price movements and trends.

DRTS Company Profile

Discover essential business fundamentals and corporate details for Alpha Tau Medical Ltd. (DRTS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

8 Mar 2021

Employees

125.00

CEO

Uzi Sofer

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

DRTS Financial Timeline

Browse a chronological timeline of Alpha Tau Medical Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 18 Nov 2025

EPS estimate is -$0.12.

Earnings released on 11 Aug 2025

EPS came in at -$0.13 falling short of the estimated -$0.12 by -8.33%.

Earnings released on 19 May 2025

EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%.

Earnings released on 12 Mar 2025

EPS came in at -$0.13 matching the estimated -$0.13.

Earnings released on 21 Nov 2024

Earnings released on 14 Aug 2024

EPS came in at -$0.11 surpassing the estimated -$0.13 by +15.38%.

Earnings released on 20 May 2024

EPS came in at -$0.11 surpassing the estimated -$0.13 by +15.38%.

Earnings released on 7 Mar 2024

EPS came in at -$0.11 surpassing the estimated -$0.13 by +15.38%.

Earnings released on 16 Nov 2023

EPS came in at -$0.07 surpassing the estimated -$0.12 by +41.67%.

Earnings released on 28 Aug 2023

EPS came in at -$0.12 surpassing the estimated -$0.13 by +7.69%.

Earnings released on 23 May 2023

EPS came in at -$0.12 falling short of the estimated -$0.09 by -33.33%.

Earnings released on 9 Mar 2023

EPS came in at -$0.04 surpassing the estimated -$0.12 by +66.67%.

Earnings released on 22 Nov 2022

EPS came in at -$0.04 surpassing the estimated -$0.10 by +60.00%.

Earnings released on 25 Aug 2022

EPS came in at -$0.03 surpassing the estimated -$0.10 by +70.00%.

Earnings released on 26 May 2022

EPS came in at -$0.54 falling short of the estimated -$0.10 by -440.00%.

Earnings released on 28 Mar 2022

EPS came in at -$0.08 .

Earnings released on 15 Nov 2021

EPS came in at -$0.07 .

Earnings released on 17 Aug 2021

EPS came in at -$0.10 .

Earnings released on 29 May 2021

EPS came in at -$0.17 .

Earnings released on 31 Dec 2020

EPS came in at -$0.03 .

Earnings released on 30 Sept 2020

EPS came in at -$0.03 .

DRTS Stock Performance

Access detailed DRTS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run